fda warning letters bpc-157 peptide not approved drug Targets GLP-1 and Compounding, Advertising and 'Research Use Only' Labeling Heal or Harm: Body Protective
Description
The relatively short half-life (24 hours) supports twice-daily dosing for more consistent effects, though once-daily protocols are more common and convenient
ClinicalTrials.gov no completed 5-Amino-1MQ human efficacy trial (evidence-gap note)
[4] Enhanced athletic performance: For fitness enthusiasts and athletes, decreasing body fat can lead to improved athletic performance
Neurological Symptoms: vitamin B12 deficiency can lead to neurological complications due to its role in maintaining the health of the nervous system
